'Decoding Targeted Therapies for Advanced Lung Cancer'

(Advanced EGFRm NSCLC- a evidence based review of Targeted therapies)

In this captivating short video, we unravel the complexities of advanced EGFRm NSCLC (Non-Small Cell Lung Cancer) and dive into an evidence-based review of targeted therapies. Join us as we explore the latest advancements in medical science and shed light on effective treatment options for this specific type of lung cancer.

Dr. Chandrani Mallik provides expert insights and analysis, backed by scientific evidence, to help viewers understand the rationale behind targeted therapies for advanced EGFRm NSCLC. Through clear explanations and visual aids, we discuss how these therapies work at a molecular level, targeting specific genetic mutations that drive cancer growth.

Our aim is to empower viewers with knowledge about personalized medicine and the importance of targeted therapies in improving outcomes for patients with advanced lung cancer. Whether you're a patient, caregiver, or simply interested in medical advancements, this video offers valuable information on cutting-edge treatments.

Click the link to watch the full video and stay informed about the latest developments in targeted therapies for advanced EGFRm NSCLC. #LungCancerAwareness #TargetedTherapies #EGFRmNSCLC #MedicalAdvancements #Shorts #YouTubeShorts #ViralVideo #HealthcareEducation #PersonalizedMedicine #CancerTreatment

Dr. Chandrani Mallik
MD, MRCP UK,MRCP MEDICAL ONCOLOGY CONSULTANT MEDICAL ONCOLOGIST
CHITTARANJAN NATIONAL CANCER INSTITUTE NEWTOWN KOLKATA